1. Consider renal function, fall risk, and polypharmacy in elderly patients. Age increases bleeding risk but benefits in reducing thromboembolic events remain.

2. For elderly patients on anticoagulants, assess kidney function, bleeding history, and concurrent medications. Therapeutic benefits must outweigh the higher risk of bleeding.

3. When prescribing anticoagulants to the elderly, monitor for age-related renal decline and potential interactions with other drugs. Balancing stroke prevention against bleeding risks is crucial.

4. In elderly anticoagulant users, evaluate fall risk, cognitive function, and adherence potential. Age amplifies both the risk of stroke and serious bleeding events.

5. Prescribing anticoagulants in the elderly requires careful assessment of liver and kidney function, evaluation of bleeding risk, and consideration of patient compliance.